Skip to main content
. 2022 May 29;2022:6721695. doi: 10.1155/2022/6721695

Table 2.

Comparison of immune function indexes between the two groups (x¯±s).

Groups n CD3+ (%) CD+4 (%) CD8+ (%) CD4+/CD8+
Observation group (n = 30) Before treatment 57.94 ± 6.22 29.32 ± 3.41 26.69 ± 2.53 1.05 ± 0.15
After treatment 68.23 ± 7.72 41.48 ± 4.03 27.20 ± 2.37 1.57 ± 0.26
t 5.685 12.627 0.805 9.386
P ≤0.001 ≤0.001 0.424 ≤0.001
Control group (n = 30) Before treatment 57.03 ± 6.95 29.50 ± 3.63 26.32 ± 2.49 1.06 ± 0.16
After treatment 62.49 ± 5.56 35.28 ± 3.61 26.45 ± 2.20 1.34 ± 0.10
t 3.357 6.1921 0.214 8.707
p 0.001 ≤0.001 0.831 ≤0.001
t1 0.534 0.209 0.570 0.255
P 0.595 0.836 0.571 0.800
t2 3.305 6.284 1.270 4.296
P 0.002 ≤0.001 0.209 ≤0.001

Note: t1 represents the comparison between the two groups before treatment, and t2 represents the comparison between the two groups after treatment.